NuVasive (NUVA) Reports In-Line Q3 EPS, Trims FY Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
NuVasive Reports Third Quarter 2016 Financial Results
October 25, 2016 5:00 PM EDTSAN DIEGO, CA -- (Marketwired) -- 10/25/16 -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today financial results for the quarter ended September 30, 2016.
Third Quarter 2016 Highlights
Revenue increased 19.5% to $239.6 million, or 18.9% on a constant currency basisGAAP operating profit margin of 8.8%; Non-GAAP operating profit margin of 16.1%GAAP diluted earnings per share of $0.07; Non-GAAP diluted earnings per share up 14.3% from prior year to... More